Ningbo David Medical Device Co., Ltd.

SZSE:300314.SZ

12.63 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

20242023202220212020201920182017201620152014201320122011201020092008
Revenue 527.026618.298506.037474.133459.531356.352300.298303.905264.949219.427227.181217.245255.79206.741177.691149.79140.407
Cost of Revenue 229.413259.641209.74182.202190.077164.745148.054147.564123.864103.515105.64198.597109.80789.8381.43772.37377.914
Gross Profit 297.613358.657296.297291.931269.453191.607152.244156.342141.085115.912121.54118.648145.983116.91196.25477.41762.493
Gross Profit Ratio 0.5650.580.5860.6160.5860.5380.5070.5140.5320.5280.5350.5460.5710.5650.5420.5170.445
Reseach & Development Expenses 55.45948.05945.86949.69440.22340.32828.25418.01314.67913.99713.7149.9719.4558.8918.3887.4955.477
General & Administrative Expenses 24.25216.86413.60213.49613.82411.38110.9837.5726.5447.3735.7374.6056.7898.1848.1198.6676.847
Selling & Marketing Expenses 70.7121.92111.567121.66284.14763.30150.76943.40734.64627.77725.79420.97125.44115.2614.65314.20512.423
SG&A 94.951138.784125.17135.15897.97174.68261.75350.97941.1935.14931.53125.57632.2323.44422.77222.87219.27
Other Expenses 78.408028.45933.82229.3621.466-2.5-1.6073.7831.1050.4241.2281.6920.913.3053.3831.303
Operating Expenses 228.819188.455199.498218.675167.555136.476107.57394.28978.86870.74967.00355.95362.28449.5446.35542.21432.907
Operating Income 68.794171.365112.0187.227147.80272.00942.39860.45970.18352.83463.62174.08985.47762.72344.17830.88227.714
Operating Income Ratio 0.1310.2770.2210.1840.3220.2020.1410.1990.2650.2410.280.3410.3340.3030.2490.2060.197
Total Other Income Expenses Net -5.412-5.1426.419-4.4714.43917.636-2.5-1.6073.6999.1989.53312.8131.649-3.804-4.53-1.0281.303
Income Before Tax 63.382166.225111.91687.193146.65269.80439.89858.85273.81253.91464.02575.30187.12563.44345.38634.12729.016
Income Before Tax Ratio 0.120.2690.2210.1840.3190.1960.1330.1940.2790.2460.2820.3470.3410.3070.2550.2280.207
Income Tax Expense 6.11918.61414.3386.98610.4627.74711.08511.81911.6468.97910.41811.22913.2589.4746.7955.1694.209
Net Income 57.263147.61197.35980.207136.1962.05728.81347.03362.16644.93453.60764.07273.86753.96938.59228.95724.807
Net Income Ratio 0.1090.2390.1920.1690.2960.1740.0960.1550.2350.2050.2360.2950.2890.2610.2170.1930.177
EPS 0.20.510.340.280.470.220.10.160.220.160.190.220.280.250.180.130.11
EPS Diluted 0.20.510.340.280.470.220.10.160.220.160.190.220.280.250.180.130.11
EBITDA 90.575188.377138.597111.774123.38786.98862.2578.52285.84663.30863.98583.6997.78676.86359.94244.5734.521
EBITDA Ratio 0.1720.3050.2740.2360.2690.2440.2070.2580.3240.2890.2820.3850.3820.3720.3370.2980.246